The End of Global Pharma Supply Chains: How Regionalization Will Impact Industry Profitability

"We are not in a transient moment - this will affect industry profitability for decades. The previous era of rule-based international trade is gone"

Frank Binder, Managing Director at GSCA (Global Supply Chain Advisors) and former Head of Supply Chain at Santen and Celgene, has watched the pharmaceutical supply chain undergo unprecedented disruption in 2025. The wave of US tariff announcements, regulatory complexity, and forced regionalization has created what he calls a fundamental shift in how the industry must operate.

Read full article